India to raise concerns over Pakistan funding at FATF, World Bank: Report
The move is part of India’s response to what it alleges are Pakistan-backed terrorist attacks, including one last month in Kashmir that killed 26 Hindu pilgrims. India has also decided to keep the Indus Waters Treaty in abeyance.
Pakistan Rangers and Indian Border Security Force soldiers lower their national flags at the India-Pakistan joint check post at Wagah border. (Photo: Reuters)
INDIA will urge the Financial Action Task Force (FATF) to put Pakistan back on its “grey list” and will oppose upcoming World Bank funding to Islamabad, a senior government official in New Delhi told Reuters on Friday.
The move is part of India’s response to what it alleges are Pakistan-backed terrorist attacks, including one last month in Kashmir that killed 26 Hindu pilgrims. India has also decided to keep the Indus Waters Treaty in abeyance.
“We will not miss any opportunity in opposing Pakistan and the next one is funding by World Bank, and we will raise our protest there too,” the Indian official told Reuters.
Pakistan was removed from the FATF grey list in 2022, which improved its standing with global lenders. The grey list includes countries under increased monitoring for shortcomings in their financial systems related to terrorist financing.
The Indian official said Pakistan had not met the necessary conditions for its removal from the grey list and should be re-listed.
India has also told the International Monetary Fund (IMF) that Pakistan’s arms purchases increased after it received IMF loans, according to the official.
The FATF, World Bank, and IMF did not respond to Reuters’ requests for comment.
Pakistan secured a $7 billion bailout from the IMF last year and a new $1.4 bn arrangement this month under a climate resilience programme.
At a press conference in Washington on Thursday, IMF director Julie Kozack said Pakistan had met all its targets and had made progress on reforms, which led the board to approve the programme.
Indian prime minister Narendra Modi said on Thursday that Pakistan, its army and its economy would “have to pay a heavy price for every terrorist attack.”
A nurse walks through an alley at the Government Medical College, where children were admitted after consuming Coldrif cough syrup, which has been linked to the deaths of multiple children, in Nagpur, India, October 8, 2025.
INDIAN police have arrested the owner of a pharmaceutical company after a cough syrup made at his plant was linked to the deaths of at least 21 children, officials said on Thursday.
Most of the children, all under the age of five, died in Madhya Pradesh over the past month after being prescribed the syrup, which was found to be contaminated with a toxic substance.
Cough syrups manufactured in India have come under global scrutiny in recent years following deaths in several countries linked to their consumption. The incidents have affected India’s reputation as the world’s third-largest producer of drugs and pharmaceuticals by volume.
G. Ranganathan, 75, was arrested early on Thursday at his home in Chennai by police teams from Chennai and Madhya Pradesh.
He was charged with culpable homicide not amounting to murder and adulteration of drugs, police sources told AFP and Indian media reported.
The syrup, sold under the brand name Coldrif, was manufactured by Sresan Pharma at a unit in Tamil Nadu.
The Indian health ministry said on Saturday that tests on samples showed contamination with diethylene glycol (DEG), a toxic chemical used in industrial solvents that can be fatal even in small quantities.
Authorities in Madhya Pradesh and several other states have banned the product.
Indian media reported that the World Health Organization had asked Indian officials for clarification on whether the contaminated syrup had been exported to other countries.
In 2022, more than 70 children died in Gambia from acute kidney failure after consuming a cough syrup imported from India.
Between 2022 and 2023, 68 children in Uzbekistan died after consuming another contaminated syrup made in India.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.